|  Help  |  About  |  Contact Us

Publication : Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis.

First Author  Christov M Year  2011
Journal  Endocrinology Volume  152
Issue  5 Pages  2031-6
PubMed ID  21427221 Mgi Jnum  J:173962
Mgi Id  MGI:5050601 Doi  10.1210/en.2010-1351
Citation  Christov M, et al. (2011) Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis. Endocrinology 152(5):2031-6
abstractText  Serum phosphate levels are regulated by PTH and the fibroblast growth factor 23 (Fgf23)/Klotho endocrine system, which both affect expression of Npt2a and thus the apical reabsorption of phosphate in the proximal renal tubules. In addition to Fgf23, secreted frizzled-related protein 4 (Sfrp4) has recently been implicated as an additional phosphate regulator in vivo and in vitro. Here we demonstrate that ablation of the Sfrp4 gene in mice does not lead to altered serum or urine phosphate levels. Furthermore, Sfrp4 is unable to compensate for the absence of Fgf23 or Klotho because double knockouts have a similar biochemical profile and phenotype as animals with ablation of Fgf23 or Klotho alone. Taken together, our data suggest that Sfrp4 does not contribute to the long-term regulation of serum phosphate levels in mice.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

8 Bio Entities

Trail: Publication

0 Expression